Nutrition in Advanced Thyroid Cancer Patients.
multikinase inhibitors
nutritional therapy
thyroid cancer
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
18 Mar 2022
18 Mar 2022
Historique:
received:
22
02
2022
revised:
14
03
2022
accepted:
17
03
2022
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
31
3
2022
Statut:
epublish
Résumé
In the last decade, multikinase inhibitors (MKIs) have changed the paradigm of treatment of advanced and progressive thyroid cancer. Compared with the traditional treatment with chemotherapy and radiotherapy, these new drugs have shown a good efficacy in controlling the neoplastic disease, and also a different toxicity profile compared to traditional chemotherapy, milder but still present and involving mainly the nutritional profile. Weight loss, nausea, anorexia, stomatitis, diarrhea may be associated with malnutrition and cancer-related cachexia. The latter is characteristic of the advanced cancer stage and may be present before starting MKIs, or may develop afterwards. Adverse events with nutritional impact may cause a significant impairment of quality of life, often requiring dose reduction and sometimes drug discontinuation, but with a lower efficacy on the neoplastic disease. The aim of this paper was to discuss the role of nutritional therapy in advanced thyroid cancer and the importance of prevention, early recognition and careful management of malnutrition and cachexia during systemic therapy with MKIs.
Identifiants
pubmed: 35334955
pii: nu14061298
doi: 10.3390/nu14061298
pmc: PMC8951395
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Ear Nose Throat J. 2009 Jul;88(7):E01
pubmed: 19623515
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Eur J Cancer. 2018 Mar;92:40-47
pubmed: 29413688
Int J Mol Sci. 2021 Mar 18;22(6):
pubmed: 33803747
J Laryngol Otol. 2016 May;130(S2):S32-S40
pubmed: 27841109
J Clin Oncol. 2013 Apr 20;31(12):1539-47
pubmed: 23530101
Ther Adv Med Oncol. 2019 Nov 13;11:1758835919880084
pubmed: 31762796
Clin Nutr. 2021 May;40(5):2898-2913
pubmed: 33946039
Bone Marrow Transplant. 2005 Jun;35(11):1113-6
pubmed: 15821765
J Am Geriatr Soc. 2002 May;50(5):889-96
pubmed: 12028177
J Clin Oncol. 2010 Feb 20;28(6):1054-60
pubmed: 20085939
Semin Cancer Biol. 2022 Feb;79:197-202
pubmed: 33476722
J Clin Endocrinol Metab. 2016 Nov;101(11):4103-4109
pubmed: 27548104
J Acad Nutr Diet. 2017 Feb;117(2):297-310.e47
pubmed: 27436529
Clin Nutr. 2017 Feb;36(1):49-64
pubmed: 27642056
ANZ J Surg. 2016 Sep;86(9):696-700
pubmed: 26573999
Clin Nutr. 2011 Feb;30(1):92-8
pubmed: 20719409
J Clin Med. 2019 Aug 14;8(8):
pubmed: 31416154
J Clin Oncol. 2012 Jan 10;30(2):134-41
pubmed: 22025146
Cancers (Basel). 2021 Jun 26;13(13):
pubmed: 34206867
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Clin Nutr. 2017 Oct;36(5):1187-1196
pubmed: 28689670
Eur Thyroid J. 2021 Jul;10(5):399-407
pubmed: 34540710
Clin Nutr. 2010 Apr;29(2):154-9
pubmed: 20060626
Surg Gynecol Obstet. 1980 Feb;150(2):229-34
pubmed: 7352315
Thyroid. 2021 Feb;31(2):224-232
pubmed: 32907501
J Clin Oncol. 2013 Oct 10;31(29):3639-46
pubmed: 24002501
J Am Med Dir Assoc. 2013 Aug;14(8):542-59
pubmed: 23867520
Cancer Discov. 2018 Jul;8(7):836-849
pubmed: 29657135
Clin Nutr. 2019 Feb;38(1):1-9
pubmed: 30181091
Support Care Cancer. 2016 Jan;24(1):469-480
pubmed: 26404858
Cell Metab. 2014 Sep 2;20(3):433-47
pubmed: 25043816
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Eur Thyroid J. 2019 Oct;8(5):227-245
pubmed: 31768334
Eur J Cancer. 1991;27(1):9-15
pubmed: 1826450
Theor Biol Med Model. 2015 Sep 15;12:17
pubmed: 26370269
Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):319-334
pubmed: 28911728
Nat Rev Dis Primers. 2018 Jan 18;4:17105
pubmed: 29345251
PLoS One. 2018 Jun 18;13(6):e0198812
pubmed: 29912922
J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
pubmed: 16684830
Clin Transl Oncol. 2019 Jan;21(1):87-93
pubmed: 30617923
Lancet. 2014 Jul 26;384(9940):319-28
pubmed: 24768112
Cancers (Basel). 2020 Dec 30;13(1):
pubmed: 33396890
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
N Engl J Med. 2015 Feb 12;372(7):621-30
pubmed: 25671254
Endocr Relat Cancer. 2017 May;24(5):237-242
pubmed: 28270435
Lipids. 2004 Dec;39(12):1187-9
pubmed: 15736914
Cancer Res. 1978 Jun;38(6):1801-7
pubmed: 647689
Eur J Cancer. 1998 Mar;34(4):503-9
pubmed: 9713300
J Clin Oncol. 2018 Jan 1;36(1):7-13
pubmed: 29072975
Int J Oncol. 2014 Jun;44(6):1843-52
pubmed: 24728273
Dyn Med. 2007 Jul 04;6:7
pubmed: 17610741
Target Oncol. 2016 Oct;11(5):605-617
pubmed: 27023922
J Nutr. 2002 Nov;132(11 Suppl):3465S-3466S
pubmed: 12421871
BMC Geriatr. 2016 Oct 5;16(1):170
pubmed: 27716195
Endocrine. 2020 Apr;68(1):132-137
pubmed: 31865555
Nutr Metab (Lond). 2011 Jul 27;8(1):54
pubmed: 21794124
Eur Thyroid J. 2020 Jan;9(1):1-10
pubmed: 32071896
Nutrients. 2021 Jun 09;13(6):
pubmed: 34207529
Eur J Cancer. 2019 Jan;106:61-68
pubmed: 30471649
BMJ. 2008 Jun 28;336(7659):1495-8
pubmed: 18583681
N Engl J Med. 2020 Aug 27;383(9):825-835
pubmed: 32846061
Dig Liver Dis. 2014 Aug;46(8):667-74
pubmed: 24794790
Cancer. 1980 Apr 15;45(8):2220-4
pubmed: 7370963
J Clin Endocrinol Metab. 2006 Jan;91(1):313-9
pubmed: 16263822